DBV Technologies Announces Updates to Food Allergy Clinical Program at 47th Annual Conference DBV Technologies, a biopharmaceutical company specializing in food allergies, announced modifications to its clinical development program during …
Tag:
FR0010417345
-
-
DBV Technologies, a late-stage biopharmaceutical company, will participate in the Guggenheim Securities Emerging Outlook: Biotech Summit. The event will be held on February 11 and 12, 2026 in New York. …